Biopharma has consistently stood at the forefront of global scientific, medical, and commercial innovation. From gene editing and personalized medicine to cell therapies and novel treatment modalities, the field is evolving at an unprecedented pace, delivering new therapeutic options to patients worldwide.
The Biopharm Industry Development Congress 2026 will be held in Shanghai, China, from November 19 to 21, 2026, under the theme “Integrating Global Vision, Driving Industrial Innovation.” This congress is positioned to be one of the most significant gatherings in the global biopharma landscape in 2026, providing an exceptional platform for exchange, collaboration, and for shaping the future trajectory of the biopharmaceutical industry.
The congress will feature a diverse range of activities, including keynote speeches by global thought leaders, scientific forums, panel discussions, exhibitions, poster presentations, and dedicated networking opportunities.
As always, the congress is committed to fostering mutual support and intellectual exchange among scientists, researchers, and industry leaders from around the world. We warmly invite international talents to join us in Shanghai to strengthen global collaboration and advance the biomedical industry toward the forefront of worldwide innovation.
1. Preparations - Paper Abstract
All the speakers are requested to write a comprehensive abstract of their research work. Please submit your abstract by email to us for review to be included in the conference.
We kindly request that you keep in mind the deadline for paper submissions: October 19, 2026.
2. Multimedia Presentation
All the speakers are suggested to make a presentation in English language. The deadline to include your presentation in the Conference Proceedings is October 19, 2026. Therefore, make sure your papers must reach our office on or before this date. Papers received after this date will not be included in the printed conference proceedings. Also, please submit your paper in MS Word format through email to us.
3. Format of Written Paper = A4
Follow the below given format for paper writing and the paper should contain the following: Font: Times New Roman, Exactly 15pt, 8, plain, bold
Headings: (Please refer to the enclosed Example Document) Name, occupation, employer of speaker Abstract Personal resume of the speaker under the heading ‘Biography’
The paper will be printed as is received without any formatting adjustment. Thus ensure all materials are of a legible print quality. The paper should not exceed 400 words.
Important Note: Copies of overheads or PowerPoint slides are NOT ACCEPTABLE as your written paper.
Chinese Society of Biotechnology
Shenzhen Center for International Exchange of Personnel
Operating Organization BIT Convention Inc.
| Conference Fee Structure | ||
|---|---|---|
| Registration Type | Academic | Business |
| Attendee | $1,499 | $1,599 |
| Speaker | $1,299 | $1,399 |
Professor, University of Lyon 1, France
Member of the National Academy of Medicine
Group Leader, Max Delbrück Center, Germany
Member of the Hungarian Academy of Sciences;
Global Head, Vaccine Drug Product Development, Sanofi, Canada
Professor, Department of Physiology,
Fellow of the Royal Society of Canada
Professor, Director of Shanghai Pharmaceutical Central Research Institute,
Shanghai Jiao Tong University, China
Professor & Dean, School of Pharmacy, Tianjin Medical University, China
CEO/President, GL Biochem (Shanghai) Ltd., Chin
The ICSICT-2026 conference is the 18th in the series aiming to provide an international forum for the presentation and d...
STSE 2026 is an international conference focusing on the theme 'Smart Classrooms 2.0: Educational Technology Tools Empow...
2026 the 12th International Conference on Mechanical and Electronics Engineering (ICMEE) is to be held in Guangzhou, Chi...
International Conference on Intelligent Commerce and Digital Economy (IC2DE 2026) is a premier international forum that...
